The following policies were recently reviewed for annual update. The full texts of these policies are available in the Provider section of bcbsri.com:
- Bariatrics
- Bone Turnover Markers for Diagnosis and Management of Osteoporosis and Diseases Associated with High Bone Turnover
- Buprenorphine for Treatment of Opioid Dependence
- Disposable Negative Pressure Wound Therapy
- Electrical Stimulation and Electromagnetic Therapy for Wound Treatments
- Fractional Carbon Dioxide (CO2) Laser Ablation Treatment of Hypertrophic Scars or Keloids for Functional Improvement
- Ingestible pH and Pressure Capsule
- Mental Illness and Substance Use Disorders Mandate
- Ocriplasmin for Symptomatic Vitreomacular Adhesion
- Optical Diagnostic Devices for Evaluating Skin Lesions Suspected of Malignancy
- Oral Nutrition Mandate
- Prostatic Stent - Temporary
- Radiofrequency Coblation Tenotomy for Musculoskeletal Conditions
- Recombinant and Autologous Platelet-Derived Growth Factors for Wound Healing and Other Non-Orthopedic Conditions
- Reflectance Confocal Microscopy for Evaluating Skin Lesions for Suspected Malignancy
- Serum Biomarker Human Epididymis Protein 4
- Stereotactic Body Radiation Therapy
- Temporarily Implanted Nitinol Device (iTind) for Benign Prostatic Hyperplasia
- Thermal Capsulorrhaphy as a Treatment of Joint Instability
- Thermography
- Thoracic Lumbosacral Orthosis with Pneumatics
- Topographic Brain Mapping
- Transanal Radiofrequency Treatment of Fecal Incontinence
- Transesophageal Endoscopic Therapies for Gastroesophageal Reflux Disease
- Transpupillary Thermotherapy for Treatment of Choroidal Neovascularization
We also post monthly drafts of medical policies being created or reassessed for your review. As a reminder, you can provide comments on draft policies for up to 30 days. Draft policies are located on the Provider homepage, under the Medical Policies section, under the “Draft Medical Policies” drop-down.